How does the saying go? “Two is always better than one.” I have always believed this to be true, especially when it comes to dessert, cars, and glasses of fine wine. When it comes to medical aesthetic treatments the sentiment also rings true.
Over the last decade or so we have seen a rapid advancement in technologies and innovations throughout the medical aesthetics sector that has paired, combined and united a variety of technologies, methodologies and treatment styles. Dual and multi treatments are a fantastic option for clients looking to treat multiple areas or address a variety of concerns in the same area, these combination treatments are known to increase the efficacy and speed of antiaging and rejuvenation procedures.
At the forefront of this booming industry is a Canadian and Israeli company, Venus Concept. First emerging on the scene in the early 2000s Venus Concept initially offered treatments designed to treat specific medical conditions the aesthetic benefits later became evident and the company expanded its reach and focus.
“The first line of products was based on unique technology combining radio waves with electromagnetic pulses,” explained Lior Darel, Venus Concept’s Marketing Lead. “The product was initially designed to treat the effects of diabetes, with beauty treatments being a side business. It soon turned out, however, that this market was bigger and more accessible.”
With wider expansion into the aesthetic beauty industry, Venus has grown the company to also include laser technology, Intense Pulsed Light (IPL) therapy, Nano-fractional radio frequency, smart scan technology. By adding these new modalities Venus can now offer whole body rejuvenation treatments making it a one-stop machine for antiaging, hair removal, body contouring, and skin tightening.
According to Jeff Nourse, Recently the innovative team at Venus announced they will be expanding into the vaginal rejuvenation market.
“Our idea of innovation is always focused towards safe, comfortable and effective treatment,” Melissa Kang, VP Global Marketing said in a press release. “We understand the concerns and need for feminine health, and have come up with Venus Fiore™, a platform for treatments resulting in internal vaginal health restoration, labia tightening, and mons pubis reduction.”
While Venus may be a frontrunner in the multi-platform aesthetic treatment sector they are not alone, as more companies begin to explore how they can combine their different treatment modalities for new and better procedures.
Allergan the makers of Botox are also looking to expand their domination of the injectable market. The Irish company recently announced they purchased Australian biotech firm Elastegen for more US$95 million. The Australian injectables company is heavily invested in technology utilizing human tropoelastin and its ability to be used for scar remodeling, surgical wound repairs, and potential aesthetic beauty applications as well.
“The acquisition and development of the next generation of injectables based on this technology will ensure Allergan offers innovative fillers products for years to come,” said Bill Meury, Allergan’s chief commercial officer.
According to Jeff Nourse, aesthetics market defines that non-surgical aesthetic services are expected to surpass $73.6 billion USD by 2022 making it one of the fastest growing sectors in the world. That number has potential to be even larger if the synergistic momentum that is uniting treatments and companies continues.